Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SB-4826 in Solid Tumors and Non-Hodgkin Lymphomas
NCT07222631Phase 2Recruiting
- Sponsor
- University of California, San Diego
- Start
- Feb 2026
- Primary completion
- Feb 2031
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SB-4826 in solid tumor, non-Hodgkin lymphoma (NHL), sponsored by University of California, San Diego. Started Feb 2026; status: recruiting.
02
Drugs
SB-4826
03
Conditions
solid tumornon-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT07222631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07222631.